Celldex Therapeutics Inc (CLDX)
2.36
-0.07 -2.88%
NASDAQ
Jul 18, 15:36
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 6.893M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -4.460 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -50.29M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -1.21K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 32.49M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 3.822 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 0.2883 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -13.42M |
| Return on Equity (TTM) | Upgrade |
View All CLDX News
News
-
WireHeadlineTime (ET)
-
Globe Newswire06/24 08:01
-
Yahoo06/06 09:31
-
Yahoo06/04 10:26
-
Yahoo06/04 07:45
-
SA Breaking News06/03 09:23
-
Globe Newswire06/01 14:15
-
Yahoo05/26 17:03
-
Yahoo05/14 12:36
-
Yahoo05/08 07:00
-
Yahoo05/07 18:15
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/08/2019 16:30 EDT | Misc | Celldex Therapeutics Inc Second Quarter Earnings Conference Call in 2019 |
| 08/08/2019 | Earnings | Celldex Therapeutics Inc Second Quarter Earnings in 2019 Release |
| 06/19/2019 09:00 EDT | Misc | Celldex Therapeutics Inc Annual General Meeting in 2018 |
| 05/07/2019 | Earnings | Celldex Therapeutics Inc First Quarter Earnings Results in 2019 |
| 03/07/2019 16:30 EST | Misc | Celldex Therapeutics Inc Fourth Quarter Earnings Conference Call in 2018 |
| 03/07/2019 | Earnings | Celldex Therapeutics Inc Fourth Quarter Earnings in 2018 Release |
| 03/07/2019 | Misc | Celldex Therapeutics Inc Annual Report in 2018 |
| 02/11/2019 | Splits | Ratio: 666667:10000000 |
| 11/07/2018 | Earnings | Celldex Therapeutics Inc Third Quarter Earnings Results in 2018 |
| 08/08/2018 16:30 EDT | Misc | Celldex Therapeutics Inc Second Quarter Earnings Conference Call in 2018 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.celldex.com
- Investor Relations URL: http://ir.celldex.com/index.cfm
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Aug. 08, 2019
- Last Earnings Release: May. 07, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 2.36 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Excel Add-In Codes
- Name: =YCI("CLDX","name")
- Description: =YCI("CLDX","description")
- Sector: =YCI("CLDX","sector")
- Industry: =YCI("CLDX","industry")
- Est. Current Fiscal Year End: =YCI("CLDX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CLDX Tweets Stocktwits
Advertisement
